# mTOR as Mediator of Insulin Sensitivity Study

> **NCT05233722** · NA · RECRUITING · sponsor: **University of Copenhagen** · enrollment: 10 (estimated)

## Conditions studied

- Insulin Sensitivity

## Interventions

- **OTHER:** Exercise
- **PROCEDURE:** Insulin infusion
- **DRUG:** Placebo
- **DRUG:** Rapamycin

## Key facts

- **NCT ID:** NCT05233722
- **Lead sponsor:** University of Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-02-10
- **Primary completion:** 2029-06
- **Final completion:** 2029-06
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05233722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05233722, "mTOR as Mediator of Insulin Sensitivity Study". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05233722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*